Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIDOC-POPEYE: Intravenous lidocaine for chronic postoperative pain after emergency abdominal surgery
2025-523682-24-00Phase 3Authorised
- Sponsor
- CHU de Nantes
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Persistent postsurgical pain (PPSP) comparing Intravenous lidocaine with Intravenous 0.9% sodium chloride (placebo) (2 arms). Planned start Aug 2026; status: authorised.
02
Drugs
lidocaine
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on 2025-523682-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523682-24-00.